In recent years, tumor cells have adapted to the TME through metabolic reprogramming, which in turn affects immune evasion and therapeutic resistance34, 35, 36, 37 UBD, an important E3 ubiquitin ligase, has been shown to play a critical role in various cancers.20 The gene discussed is UBD; the disease is neoplasm.